Identification of a Prognostic Gene Signature Based on Lipid Metabolism-Related Genes in Esophageal Squamous Cell Carcinoma

Guo-Yi Shen,1,* Peng-Jie Yang,2,* Wen-Shan Zhang,1 Jun-Biao Chen,1 Qin-Yong Tian,1 Yi Zhang,1 Bater Han2 1Department of Cardiothoracic Surgery, Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou, 363000, People’s Republic of China; 2Department of Thoracic Surgery,...

Full description

Bibliographic Details
Main Authors: Shen GY, Yang PJ, Zhang WS, Chen JB, Tian QY, Zhang Y, Han B
Format: Article
Language:English
Published: Dove Medical Press 2023-11-01
Series:Pharmacogenomics and Personalized Medicine
Subjects:
Online Access:https://www.dovepress.com/identification-of-a-prognostic-gene-signature-based-on-lipid-metabolis-peer-reviewed-fulltext-article-PGPM
_version_ 1797636593227399168
author Shen GY
Yang PJ
Zhang WS
Chen JB
Tian QY
Zhang Y
Han B
author_facet Shen GY
Yang PJ
Zhang WS
Chen JB
Tian QY
Zhang Y
Han B
author_sort Shen GY
collection DOAJ
description Guo-Yi Shen,1,* Peng-Jie Yang,2,* Wen-Shan Zhang,1 Jun-Biao Chen,1 Qin-Yong Tian,1 Yi Zhang,1 Bater Han2 1Department of Cardiothoracic Surgery, Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou, 363000, People’s Republic of China; 2Department of Thoracic Surgery, Inner Mongolia Cancer Hospital & Affiliated People’s Hospital of Inner Mongolia Medical University, Huhhot, Inner Mongolia Autonomous Region, 010020, People’s Republic of China*These authors contributed equally to this workCorrespondence: Yi Zhang, Department of Cardiothoracic Surgery, Zhangzhou Affiliated Hospital of Fujian Medical University, No. 59, Shengli West Road, Zhangzhou Xiangcheng District, Zhangzhou, 363000, People’s Republic of China, Tel +86-13906969033, Email zhangyi625@126.com Bater Han, Department of Thoracic Surgery, Inner Mongolia Cancer Hospital & Affiliated People’s Hospital of Inner Mongolia Medical University, No. 42, Zhaowuda Road, Saihan District, Huhhot, Inner Mongolia Autonomous Region, 010020, People’s Republic of China, Tel +86-13948120033, Email baterhanhbb@126.comBackground: Dysregulation of lipid metabolism is common in cancer. However, the molecular mechanism underlying lipid metabolism in esophageal squamous cell carcinoma (ESCC) and its effect on patient prognosis are not well understood. The objective of our study was to construct a lipid metabolism-related prognostic model to improve prognosis prediction in ESCC.Methods: We downloaded the mRNA expression profiles and corresponding survival data of patients with ESCC from the Gene Expression Omnibus (GEO) and The Cancer Genome Atlas (TCGA) databases. We performed differential expression analysis to identify differentially expressed lipid metabolism-related genes (DELMGs). We used Univariate Cox regression and least absolute shrinkage and selection operator (LASSO) analyses to establish a risk model in the GEO cohort and used data of patients with ESCC from the TCGA cohort for validation. We also explored the relationship between the risk model and the immune microenvironment via infiltrated immune cells and immune checkpoints.Results: The result showed that 132 unique DELMGs distinguished patients with ESCC from the controls. We identified four genes (ACAA1, ACOT11, B4GALNT1, and DDHD1) as prognostic gene expression signatures to construct a risk model. Patients were classified into high- and low-risk groups as per the signature-based risk score. We used the receiver operating characteristic (ROC) curve and the Kaplan-Meier (KM) survival analysis to validate the predictive performance of the 4-gene signature in both the training and validation sets. Infiltrated immune cells and immune checkpoints indicated a difference in the immune status between the two risk groups.Conclusion: The results of our study indicated that a prognostic model based on the 4-gene signature related to lipid metabolism was useful for the prediction of prognosis in patients with ESCC.Keywords: biomarkers, esophageal squamous cell carcinoma, immune microenvironment, lipid metabolism, prognosis
first_indexed 2024-03-11T12:36:18Z
format Article
id doaj.art-1cf77fd810a94783921009827ef2c9b6
institution Directory Open Access Journal
issn 1178-7066
language English
last_indexed 2024-03-11T12:36:18Z
publishDate 2023-11-01
publisher Dove Medical Press
record_format Article
series Pharmacogenomics and Personalized Medicine
spelling doaj.art-1cf77fd810a94783921009827ef2c9b62023-11-05T18:06:31ZengDove Medical PressPharmacogenomics and Personalized Medicine1178-70662023-11-01Volume 1695997287885Identification of a Prognostic Gene Signature Based on Lipid Metabolism-Related Genes in Esophageal Squamous Cell CarcinomaShen GYYang PJZhang WSChen JBTian QYZhang YHan BGuo-Yi Shen,1,* Peng-Jie Yang,2,* Wen-Shan Zhang,1 Jun-Biao Chen,1 Qin-Yong Tian,1 Yi Zhang,1 Bater Han2 1Department of Cardiothoracic Surgery, Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou, 363000, People’s Republic of China; 2Department of Thoracic Surgery, Inner Mongolia Cancer Hospital & Affiliated People’s Hospital of Inner Mongolia Medical University, Huhhot, Inner Mongolia Autonomous Region, 010020, People’s Republic of China*These authors contributed equally to this workCorrespondence: Yi Zhang, Department of Cardiothoracic Surgery, Zhangzhou Affiliated Hospital of Fujian Medical University, No. 59, Shengli West Road, Zhangzhou Xiangcheng District, Zhangzhou, 363000, People’s Republic of China, Tel +86-13906969033, Email zhangyi625@126.com Bater Han, Department of Thoracic Surgery, Inner Mongolia Cancer Hospital & Affiliated People’s Hospital of Inner Mongolia Medical University, No. 42, Zhaowuda Road, Saihan District, Huhhot, Inner Mongolia Autonomous Region, 010020, People’s Republic of China, Tel +86-13948120033, Email baterhanhbb@126.comBackground: Dysregulation of lipid metabolism is common in cancer. However, the molecular mechanism underlying lipid metabolism in esophageal squamous cell carcinoma (ESCC) and its effect on patient prognosis are not well understood. The objective of our study was to construct a lipid metabolism-related prognostic model to improve prognosis prediction in ESCC.Methods: We downloaded the mRNA expression profiles and corresponding survival data of patients with ESCC from the Gene Expression Omnibus (GEO) and The Cancer Genome Atlas (TCGA) databases. We performed differential expression analysis to identify differentially expressed lipid metabolism-related genes (DELMGs). We used Univariate Cox regression and least absolute shrinkage and selection operator (LASSO) analyses to establish a risk model in the GEO cohort and used data of patients with ESCC from the TCGA cohort for validation. We also explored the relationship between the risk model and the immune microenvironment via infiltrated immune cells and immune checkpoints.Results: The result showed that 132 unique DELMGs distinguished patients with ESCC from the controls. We identified four genes (ACAA1, ACOT11, B4GALNT1, and DDHD1) as prognostic gene expression signatures to construct a risk model. Patients were classified into high- and low-risk groups as per the signature-based risk score. We used the receiver operating characteristic (ROC) curve and the Kaplan-Meier (KM) survival analysis to validate the predictive performance of the 4-gene signature in both the training and validation sets. Infiltrated immune cells and immune checkpoints indicated a difference in the immune status between the two risk groups.Conclusion: The results of our study indicated that a prognostic model based on the 4-gene signature related to lipid metabolism was useful for the prediction of prognosis in patients with ESCC.Keywords: biomarkers, esophageal squamous cell carcinoma, immune microenvironment, lipid metabolism, prognosishttps://www.dovepress.com/identification-of-a-prognostic-gene-signature-based-on-lipid-metabolis-peer-reviewed-fulltext-article-PGPMbiomarkersesophageal squamous cell carcinomaimmune microenvironmentlipid metabolismprognosis
spellingShingle Shen GY
Yang PJ
Zhang WS
Chen JB
Tian QY
Zhang Y
Han B
Identification of a Prognostic Gene Signature Based on Lipid Metabolism-Related Genes in Esophageal Squamous Cell Carcinoma
Pharmacogenomics and Personalized Medicine
biomarkers
esophageal squamous cell carcinoma
immune microenvironment
lipid metabolism
prognosis
title Identification of a Prognostic Gene Signature Based on Lipid Metabolism-Related Genes in Esophageal Squamous Cell Carcinoma
title_full Identification of a Prognostic Gene Signature Based on Lipid Metabolism-Related Genes in Esophageal Squamous Cell Carcinoma
title_fullStr Identification of a Prognostic Gene Signature Based on Lipid Metabolism-Related Genes in Esophageal Squamous Cell Carcinoma
title_full_unstemmed Identification of a Prognostic Gene Signature Based on Lipid Metabolism-Related Genes in Esophageal Squamous Cell Carcinoma
title_short Identification of a Prognostic Gene Signature Based on Lipid Metabolism-Related Genes in Esophageal Squamous Cell Carcinoma
title_sort identification of a prognostic gene signature based on lipid metabolism related genes in esophageal squamous cell carcinoma
topic biomarkers
esophageal squamous cell carcinoma
immune microenvironment
lipid metabolism
prognosis
url https://www.dovepress.com/identification-of-a-prognostic-gene-signature-based-on-lipid-metabolis-peer-reviewed-fulltext-article-PGPM
work_keys_str_mv AT shengy identificationofaprognosticgenesignaturebasedonlipidmetabolismrelatedgenesinesophagealsquamouscellcarcinoma
AT yangpj identificationofaprognosticgenesignaturebasedonlipidmetabolismrelatedgenesinesophagealsquamouscellcarcinoma
AT zhangws identificationofaprognosticgenesignaturebasedonlipidmetabolismrelatedgenesinesophagealsquamouscellcarcinoma
AT chenjb identificationofaprognosticgenesignaturebasedonlipidmetabolismrelatedgenesinesophagealsquamouscellcarcinoma
AT tianqy identificationofaprognosticgenesignaturebasedonlipidmetabolismrelatedgenesinesophagealsquamouscellcarcinoma
AT zhangy identificationofaprognosticgenesignaturebasedonlipidmetabolismrelatedgenesinesophagealsquamouscellcarcinoma
AT hanb identificationofaprognosticgenesignaturebasedonlipidmetabolismrelatedgenesinesophagealsquamouscellcarcinoma